Spravato
Esketamine nasal spray, the FDA-approved version of ketamine for treatment-resistant depression and major depression with acute suicidal ideation. Same mechanism as IV ketamine; different administration route.
Which Procedures Involve Spravato?
Spravato appears in the following procedure guides on ProcedureFinder:
Frequently Asked Questions
What is Spravato? +
Esketamine nasal spray, the FDA-approved version of ketamine for treatment-resistant depression and major depression with acute suicidal ideation. Same mechanism as IV ketamine; different administration route. On ProcedureFinder, Spravato appears in the Ketamine Infusion Therapy cost guide. IV ketamine has substantial published evidence for rapid antidepressant effects in treatment-resistant depression, including multiple RCTs showing 60-70% response rates and 30-40% remission rates after a single infusion.
How much does ketamine infusion therapy cost? +
Ketamine Infusion Therapy costs $350 to $850 per infusion (induction series typically 6 infusions) nationally, with a median of $525 in ProcedureFinder's cash-pay benchmarks. IV ketamine infusion series for treatment-resistant depression, PTSD, and chronic pain. Standard induction protocol is six infusions over 2-3 weeks.